Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary

NCT04325425 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

218

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Carcinoma

Interventions

DRUG: FOLFOXIRI Protocol
DRUG: Cisplatin injection

Sponsor

Centre Hospitalier Universitaire Dijon

Collaborators

[object Object]